Information is from various sources including GKC
URGENT: Oppose the Delaware Kratom Ban (SS1-SB262) & Support Regulation (HB332)
SB262 An Act To Amend Title 16 Of The Delaware Code Relating To The Uniform Controlled Substances Act.
Status: (Introduced) 2026-04-15 – Adopted in lieu of the original bill SB 262
Assigned to Health & Social Services Committee in Senate [SB262 S1 Detail]
Committee email: SenateHealthSocialServices@delaware.gov
| Name | Phone Number | Email Address |
| Marie Pinkney, Chair | 302-744-4167 | Marie.Pinkney@delaware.gov |
| Bryan Townsend, Vice Chair | 302-744-4165 | Bryan.Townsend@delaware.gov |
| Kyra Hoffner | 302-744-4187 | Kyra.Hoffner@delaware.gov |
| Bryant Richardson | 302-744-4298 | Bryant.Richardson@delaware.gov |
| Ronald Grey | 302-744-4171 | Ronald.Gray@delaware.gov |
| Stephanie Hanson | 302-744-4138 | Stephanie.Hansen@delaware.gov |
| Russell Huxtable | (302) 744-4182 | russell.huxtable@delaware.gov |
| Nicole Poore | 302-744-4164 | Nicole.Poore@delaware.gov |
| Ray Siegfried | 302-744-4137 | ray.seigfried@delaware.gov |
| Eric Buckson | 302-744-4169 | eric.buckson@delaware.gov |
| David Wilson | 302-744-4048 | David.L.Wilson@delaware.gov |
Email Template: Support Regulation (HB332) over Prohibition (SS1 SB 262)
Subject: Oppose SS1-SB262 / Support HB332 – Protecting Delaware Consumers
Dear Senator [Representative Name],
I am writing to you today as a constituent to express my strong opposition to SS1 SB 262 and my firm support for HB 332.
While I understand the intent to address public health concerns regarding Kratom, SB 262 takes an extreme approach by adding Kratom to the Uniform Controlled Substances Act as a Schedule I substance. This “all-or-nothing” prohibition would:
- Criminalize Law-Abiding Citizens: Thousands of Delawareans safely use Kratom for wellness and as an alternative to more dangerous substances. Prohibition would turn these residents into criminals overnight.
- Create an Unregulated Underground Market: Banning a substance does not eliminate demand; it simply removes oversight, leading to the sale of potentially dangerous, adulterated products without any safety standards.
Instead, I urge you to support HB 332. This bill provides a common-sense regulatory framework that protects Delawareans by:
- Ensuring Product Purity: Setting standards to prevent the sale of contaminated or dangerously concentrated products.
- Implementing Age Restrictions: Prohibiting the sale of Kratom to minors.
- Mandating Proper Labeling: Requiring clear ingredients and usage instructions.
Regulation, not prohibition, is the most effective way to protect public health while respecting the personal liberties of Delaware citizens. Please vote NO on SS1-B262 and YES on HB332.
Thank you for your time and for your service to our state.
Sincerely,
[Your Name]
[Your Address]
[Your Phone Number]
HB332 An Act To Amend Title 16 Of The Delaware Code Relating To Kratom.
Status: Introduced on March 26 2026 – 25% progression
Action: 2026-03-26 – Introduced and Assigned to Health & Human Development Committee in House
Pending: House Health & Human Development Committee
Hearing: Apr 15 @ 11:30 am in House Chamber
Bill text HB332
Read the Meeting Notice which includes the link to REGISTER and find the LIVESTREAM
Date: April 15, 2026 11:30 am EST House Chamber
Where: Legislative Hall
411 Legislative Avenue
Dover, DE 19901
Public comments can be sent to the committee at HouseCommitteeComment@delaware.gov and to the committee members separately which are listed below.
It is best to send each one separately so that it does not get marked as spam.
Committee Leadership
| Name | Role | Phone | |
| Nnamdi O. Chukwuocha | Chair | 302-744-4351 | nnamdi.chukwuocha@delaware.gov |
| DeShanna U. Neal | Vice-Chair | 302-744-4351 | deshanna.neal@delaware.gov |
Committee Members
| Name | Phone | |
| Frank Burns | 302-744-4351 | frank.burns@delaware.gov |
| Kerri Evelyn Harris | 302-744-4351 | kerri.harris@delaware.gov |
| Debra Heffernan | 302-744-4351 | debra.heffernan@delaware.gov |
| Kendra Johnson | 302-744-4351 | kendra.johnson@delaware.gov |
| Eric Morrison | 302-744-4351 | eric.morrison@delaware.gov |
HB 332 Advocacy Letter Template
Subject: Support for HB 332 – Favoring Regulation Over Prohibitive Scheduling
To: Representative [Member Name] Delaware House Health & Human Development Committee
Date: April 10, 2026
Dear Representative [Member Last Name],
My name is [Your Name], and I am a resident of [Your City/District]. I am writing to you today to express my strong support for the regulatory framework proposed in HB332. Specifically, I urge the Committee to move forward with strict consumer protections and industry oversight rather than pursuing the “scheduling” or prohibition of this substance of SB262.
While the intent of scheduling is often to protect public health, history shows that outright prohibition frequently leads to unintended negative consequences, including the growth of unregulated “gray markets” and the removal of access for responsible adult consumers.
I believe that regulation, as outlined in HB 332, is the more effective and modern approach for the following reasons:
- Consumer Safety: HB 332 ensures that products are laboratory-tested, free of contaminants, and accurately labeled. Scheduling removes these products from the light of oversight, leaving consumers at higher risk.
- Age Restrictions: This bill establishes clear legal age requirements, ensuring these products remain out of the hands of minors while allowing adults to make informed choices.
- Economic Impact: By regulating the industry rather than banning it, Delaware can support local small businesses and generate specialized tax revenue that can be reinvested into public health education.
- Evidence-Based Policy: Regulation allows the state to monitor usage trends and maintain a dialogue with stakeholders, whereas scheduling creates a “one-size-fits-all” barrier that is difficult to reverse even when new data emerges.
I trust in the Committee’s ability to balance public safety with personal liberty. Please support HB 332 to ensure that Delaware remains a leader in common-sense, safety-first botanical and supplement regulation.
Thank you for your time and for your dedicated service to our state.
Sincerely,
[Your Name] [Your Address] [Your Phone Number] [Your Email]
Submission Tips
The committee has a meeting scheduled for 4/15/26 at 11:30 AM. Send your correspondence at least 24–48 hours before the meeting.
Personalize the first paragraph: Mentioning your specific profession or how this issue affects you personally makes the letter significantly more impactful.
Target the Chair: If you only send one email, send it to the Committee Chair, Nnamdi O. Chukwuocha.